ATE397451T1 - Flüssigkeit für die hämofiltration - Google Patents

Flüssigkeit für die hämofiltration

Info

Publication number
ATE397451T1
ATE397451T1 AT01979074T AT01979074T ATE397451T1 AT E397451 T1 ATE397451 T1 AT E397451T1 AT 01979074 T AT01979074 T AT 01979074T AT 01979074 T AT01979074 T AT 01979074T AT E397451 T1 ATE397451 T1 AT E397451T1
Authority
AT
Austria
Prior art keywords
fluid
mmol
haemofiltration
concentration
ions
Prior art date
Application number
AT01979074T
Other languages
English (en)
Inventor
Adrianus Antonius Ma Hollander
Original Assignee
Adrianus Antonius Ma Hollander
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19772121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE397451(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adrianus Antonius Ma Hollander filed Critical Adrianus Antonius Ma Hollander
Application granted granted Critical
Publication of ATE397451T1 publication Critical patent/ATE397451T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AT01979074T 2000-09-21 2001-09-21 Flüssigkeit für die hämofiltration ATE397451T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1016235A NL1016235C2 (nl) 2000-09-21 2000-09-21 Vloeistof voor hemofiltratie.

Publications (1)

Publication Number Publication Date
ATE397451T1 true ATE397451T1 (de) 2008-06-15

Family

ID=19772121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979074T ATE397451T1 (de) 2000-09-21 2001-09-21 Flüssigkeit für die hämofiltration

Country Status (11)

Country Link
US (1) US20040022816A1 (de)
EP (1) EP1318821B1 (de)
AT (1) ATE397451T1 (de)
AU (1) AU2002211063A1 (de)
CY (1) CY1108251T1 (de)
DE (1) DE60134327D1 (de)
DK (1) DK1318821T3 (de)
ES (1) ES2307655T3 (de)
NL (1) NL1016235C2 (de)
PT (1) PT1318821E (de)
WO (1) WO2002024209A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2206504A4 (de) * 2007-10-05 2014-02-12 Univ Chiba Nat Univ Corp Stabile ionenhaltige bicarbonat-arzneimittellösung
DE102015015597A1 (de) * 2015-12-04 2017-06-08 Fresenius Medical Care Deutschland Gmbh Behandlung von Schlaganfall durch Hämofiltration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632913B1 (fr) 1988-06-15 1990-09-14 Bendix France Circuit hydraulique de freinage pour vehicule automobile equipe de dispositifs d'antiblocage et d'antipatinage de roues
DE3917251A1 (de) * 1989-05-26 1990-11-29 Fresenius Ag Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit
DE4122754A1 (de) * 1991-07-10 1993-01-21 Martin Prof Dr Med Vlaho Herstellung einer substitutionsloesung fuer die haemofiltration bei dialyseverfahren
US5616248A (en) * 1992-04-06 1997-04-01 Schal; Wilfried Method for the preparation of hemodialysis fluids containing bicarbonate
EP0613688B2 (de) 1993-02-19 2004-08-18 Wilfried Dr.-Ing. Schäl Verfahren zur Bereitung von bicarbonathaltigen Dialysierflüssigkeiten für die Hämodialyse
EP0658353A1 (de) 1993-11-19 1995-06-21 Bertold Dr. Reinhardt Pyruvathaltige CAPD- und Substitutionslösungen sowie pyruvathaltige Dialysierflüssigkeiten
SI9400289A (en) * 1994-07-13 1996-02-29 Ponikvar Jadranka Buturovic A method for preventing blood coagulation in a haemodialysis circuit or haemodialysis analogy procedure in the extra-body circuit.

Also Published As

Publication number Publication date
NL1016235C2 (nl) 2002-03-22
ES2307655T3 (es) 2008-12-01
DK1318821T3 (da) 2008-09-29
DE60134327D1 (de) 2008-07-17
EP1318821A1 (de) 2003-06-18
PT1318821E (pt) 2008-11-13
CY1108251T1 (el) 2014-02-12
US20040022816A1 (en) 2004-02-05
AU2002211063A1 (en) 2002-04-02
EP1318821B1 (de) 2008-06-04
WO2002024209A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE294597T1 (de) Lösung für die peritonealdialyse
BE861002A (fr) T-butyl-phenyl-prop(en)yl-amines et leurs n-oxydes, agents fongicides les contenant, ainsi que procede de preparation.
DE3578578D1 (de) Hirudin-pa und dessen derivate, verfahren zu deren herstellung und deren verwendung.
EP0361955A3 (de) Hydrokultur
DE69932313D1 (de) Wässerige flüssige zubereitungen
ATE75141T1 (de) Waesserige abfuehrende loesung.
NO885836L (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opploesning.
EP1329461A4 (de) Verfahren zur verhinderung von polymeren des humanen serumalbumins
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
Agrawal Correction factors for the glass electrode in aqueous dioxan
FR2866890B1 (fr) Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
ES489205A1 (es) Procedimiento y medio para la eliminacion de acido ascorbicoa partir de soluciones acuosas
CY1108251T1 (el) Υγρο για αιμοκαθαρση
FR2773712B1 (fr) Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
RU94038542A (ru) Способ определения биологического возраста человека
DE69905489D1 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
ES8707563A1 (es) Un procedimiento para purificar urocinasa
SE9003181D0 (sv) Use of heparin fraction
ATE122563T1 (de) Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
RU2001129744A (ru) Способ лечения бациллярных форм туберкулеза легких
DK1369122T3 (da) Anticancermiddel
BR0211733A (pt) Sais de derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilìco substituìdos
Koelsch A deeper understanding of machining

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1318821

Country of ref document: EP